Adipositastherapie – werden Pharmakotherapien die Alternative zur metabolischen Chirurgie sein?

por Müller, Timo D., Blüher, Matthias
Publicado 2023

The molecular pharmacology of glucagon agonists in diabetes and obesity

por Novikoff, Aaron, Müller, Timo D.
Publicado 2023

Relationship status update for PTP1B and LepR: It׳s complicated()

por Fischer, Katrin, Müller, Timo D.
Publicado 2014

Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue “The Biology and Pharmacology of Glucagon”

por Müller, Timo D., Habegger, Kirk
Publicado 2020

Transfer of Proteins from Cultured Human Adipose to Blood Cells and Induction of Anabolic Phenotype Are Controlled by Serum, Insulin and Sulfonylurea Drugs

por Müller, Günter A., Müller, Timo D.
Publicado 2023

(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins I: Localization at Plasma Membranes and Extracellular Compartments

por Müller, Günter A., Müller, Timo D.
Publicado 2023

(Patho)Physiology of Glycosylphosphatidylinositol-Anchored Proteins II: Intercellular Transfer of Matter (Inheritance?) That Matters

por Müller, Günter A., Müller, Timo D.
Publicado 2023

Incretin hormones and type 2 diabetes

por Nauck, Michael A., Müller, Timo D.
Publicado 2023

Biological Role of the Intercellular Transfer of Glycosylphosphatidylinositol-Anchored Proteins: Stimulation of Lipid and Glycogen Synthesis

por Müller, Günter A., Müller, Timo D.
Publicado 2022

Emerging Function of Fat Mass and Obesity-Associated Protein (Fto)

por Müller, Timo D., Tschöp, Matthias H., Hofmann, Susanna
Publicado 2013

Therapeutic Potential of Targeting the Ghrelin Pathway

por Colldén, Gustav, Tschöp, Matthias H., Müller, Timo D.
Publicado 2017

Ghrelin regulation of glucose metabolism

por Poher, Anne-Laure, Tschöp, Matthias H., Müller, Timo D.
Publicado 2018

Chip-Based Sensing of the Intercellular Transfer of Cell Surface Proteins: Regulation by the Metabolic State

por Müller, Günter A., Tschöp, Matthias H., Müller, Timo D.
Publicado 2021

Gut hormone polyagonists for the treatment of type 2 diabetes

por Brandt, Sara J., Götz, Anna, Tschöp, Matthias H., Müller, Timo D.
Publicado 2018

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)

por Müller, Günter A., Herling, Andreas W., Wied, Susanne, Müller, Timo D.
Publicado 2020

Interaction of Full-Length Glycosylphosphatidylinositol-Anchored Proteins with Serum Proteins and Their Translocation to Cells In Vitro Depend on the (Pre-)Diabetic State in Rats a...

por Müller, Günter A., Lechner, Andreas, Tschöp, Matthias H., Müller, Timo D.
Publicado 2021

Anti-obesity drug discovery: advances and challenges

por Müller, Timo D., Blüher, Matthias, Tschöp, Matthias H., DiMarchi, Richard D.
Publicado 2021

Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia

por Müller, Timo D., Perez-Tilve, Diego, Tong, Jenny, Pfluger, Paul T., Tschöp, Matthias H.
Publicado 2010

Glucagon Regulation of Energy Expenditure

por Kleinert, Maximilian, Sachs, Stephan, Habegger, Kirk M., Hofmann, Susanna M., Müller, Timo D.
Publicado 2019

Dual specificity phosphatase 6 deficiency is associated with impaired systemic glucose tolerance and reversible weight retardation in mice

por Pfuhlmann, Katrin, Pfluger, Paul T., Schriever, Sonja C., Müller, Timo D., Tschöp, Matthias H., Stemmer, Kerstin
Publicado 2017